Influenza genome sequencing now available

WASHINGTON, March 1 (UPI) -- U.S. scientists say the genetic blueprints of more than 2,000 human and avian influenza viruses worldwide have been completed and made public.

AIDS vaccine design: Closer to reality

BETHESDA, Md., Feb. 14 (UPI) -- U.S. scientists have generated an atomic picture of part of the human immunodeficiency virus in a move that could greatly help AIDS vaccine design.

Male circumcision found safe, effective

WASHINGTON, Dec. 13 (UPI) -- National Institutes of Health officials say there is now substantial proof male circumcision is effective in limiting transmission of the AIDS virus. The National Institute of Allergy and Infectious Diseases, part of the NIH, said it stopped two African c

Staph vaccine shows promise in mouse study

CHICAGO, Oct. 31 (UPI) -- A U.S. scientist has created a vaccine that, in a mouse study, significantly protected the animals from various strains of Staphylococcus aureus.

Vaccine protects mice from 1918 flu virus

WASHINGTON, Oct. 17 (UPI) -- U.S. medical researchers say they've developed a vaccine that protects mice against the killer 1918 influenza virus. The National Institutes of Health scientists say they also have created a technique for identifying antibodies that neutralize that deadly

Virulence of 1918 flu virus studied

ATLANTA, Oct. 2 (UPI) -- U.S. scientists have completed the first comprehensive analysis of an animal's immune response to the 1918 influenza virus.

Anti-radiation treatment studies funded

WASHINGTON, Sept. 25 (UPI) -- The U.S. National Institute of Allergy and Infectious Diseases has announced five awards totaling $4 million to fund a study of anti-radiation treatments.

Study: Live H5N1 virus vaccines effective

WASHINGTON, Sept. 12 (UPI) -- U.S. scientists say live, weakened versions of differing strains of avian flu viruses have offered protection when tested in mice and ferrets. Researchers say their findings are encouraging because they demonstrate the ability to create a vaccine based on

Quicker avian flu diagnosis developed

WASHINGTON, Aug. 29 (UPI) -- U.S. scientists report developing a microchip that cuts the time needed for a detailed diagnosis of avian flu from a week or more to fewer than 12 hours.

Prion disease may cause heart damage

WASHINGTON, July 12 (UPI) -- U.S. government scientists say laboratory mice infected with the agent of scrapie, a prion disease, might be at risk for heart damage.

HIV/AIDS clinical trials networks revised

WASHINGTON, June 29 (UPI) -- The U.S. National Institute of Allergy and Infectious Diseases announced Thursday the new structure of its HIV/AIDS clinical trials networks.

Disease model details HIV therapies

WASHINGTON, June 6 (UPI) -- U.S. government scientists say increasingly effective HIV therapies have provided 3 million years of total extended life to Americans with AIDS since 1989.

Scientists build anthrax toxin inhibitor

WASHINGTON, April 24 (UPI) -- U.S. and Canadian scientists say they have engineered a powerful inhibitor of anthrax toxin that has worked well in small-scale animal tests.

Major Kaposi's sarcoma discovery announced

BETHESDA, Md., April 6 (UPI) -- Government scientists say they've found a human cell surface molecule involved with the Kaposi's sarcoma herpes virus.

Bird flu vaccine effectiveness questioned.

NEW YORK, March 30 (UPI) -- A new U.S. study has questioned the effectiveness of the bird flu vaccine the government is stockpiling to fight a possible pandemic.
Page 2 of 7
Anthony Fauci
WAP2002011487 - 14 JANUARY 2002 - WASHINGTON, D. C., USA: Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Disease, speaks at a National Press Club Newsmaker luncheon in Washington, January 14, 2002. He discussed issues surrounding the recent Anthrax mail attacks around the country and how they have irrevocably altered american medicine and public health. rw/Ricardo Watson. UPI

Anthony S. Fauci (born: December 24, 1940) is an immunologist who has made substantial contributions to research in the areas of AIDS and other immunodeficiencies, both as a scientist and as the head of the National Institute of Allergy and Infectious Diseases (NIAID).

Anthony Stephen Fauci was born on December 24, 1940, in Brooklyn, New York, to Stephen A. Fauci, a pharmacist, and Eugenia A. Fauci, a homemaker. He graduated from the all-scholarship, Jesuit-run Regis High School in New York City. He went on to attend the College of the Holy Cross and later received his M.D. from Cornell University Medical College in 1966. He then completed an internship and residency at The New York Hospital-Cornell Medical Center.

In 1968, Fauci came to the National Institutes of Health (NIH) as a clinical associate in the Laboratory of Clinical Investigation (LCI) in NIAID. In 1974, he became Head of the Clinical Physiology Section, LCI, and in 1980 was appointed Chief of the Laboratory of Immunoregulation, a position he still holds. In 1984, Fauci became Director of NIAID, where he oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat infectious and immune-mediated illnesses, including HIV/AIDS and other sexually transmitted diseases, illness from potential agents of bioterrorism, tuberculosis, malaria, autoimmune disorders, asthma and allergies.

This article is licensed under the GNU Free Documentation License.
It uses material from the Wikipedia article "Anthony Fauci."
Most Popular
Stratosphere crash driver commits suicide Stratosphere crash driver commits suicide
U.S. intercepts two Russian fighter jets near Alaska
Kim Zolciak denies Photoshopping in Instagram pics Kim Zolciak denies Photoshopping in Instagram pics
Boko Haram, Nigeria negotiating release of kidnapped girls Boko Haram, Nigeria negotiating release of kidnapped girls
Marine detained in Mexico is 'highly despondent' Marine detained in Mexico is 'highly despondent'